
Aidoc, a NYC-based clinical AI company, has raised $150 million in a Series E funding round led by Growth Equity at Goldman Sachs Alternatives with participation from General Catalyst, SoftBank Investment Advisors, and NVentures. The raise brought the total amount to over $500M.
The company plans to use the funds to develop its CARE foundation model further, expand into new clinical uses, and add features such as automated imaging report drafts to support complete AI-driven clinical workflows.
It will also support wider global rollout of its aiOS platform as hospitals move from separate tools to centralized systems that manage AI at scale.
As hospitals look for broader, system-wide solutions, clinical AI is moving toward use across entire health systems. Foundation models have made this possible by supporting many conditions and imaging types within one system, but applying this in real, regulated healthcare settings remains complex. Aidoc addressed this by developing its CARE model and deploying it through its aiOS platform.
RECOMMENDED FOR YOU
Globant Acquires Exusia To Continue Expanding Its Data & AI Offering
Startuprise
Oct 7, 2024
Earlier this year, CARE received FDA clearance for a foundation–model–based triage system for clinical imaging. Today, Aidoc analyzes over 60 million patient cases each year and is used in nearly 2,000 hospitals, showing growing adoption of clinical AI.
Diagnostic errors and delays cause at least 400,000 deaths each year in the United States, driven by higher imaging volumes, staff shortages and increasing complexity. While AI has aimed to reduce this problem most tools focus on only one use case, limiting their impact at scale.
Read More:definity Raises $12M in Series A Funding Led by GreatPoint Ventures
"By 2030 every complex diagnostic decision should be supported by AI that enables earlier detection and reduces preventable error," said Elad Walach co founder and CEO of Aidoc. "We feel a deep responsibility to deploy CARE safely, and at scale across health systems. This funding accelerates comprehensive disease coverage and advances end-to-end AI across CT, and X ray, spanning the full workflow, including pixel to draft report within two years."
"Aidoc pairs advanced technology with regulatory rigor in a way that few companies have achieved, said Christian Resch Partner at Growth Equity at Goldman Sachs Alternatives. "Health systems consistently describe tangible results including improved radiology efficiency shorter lengths of stay and measurable financial returns. We believe this combination of innovation safety technical rigor and operational discipline positions Aidoc as a long term leader in clinical AI."
About Aidoc
Founded in 2016 by Elad Walach Aidoc is a global clinical AI company that helps doctors make faster, safer diagnoses by turning patient data into actionable insights. Its CARE foundation model, and aiOS platform integrate AI directly into clinical workflows, allowing hospitals to deploy and manage multiple FDA cleared tools in one system. Aidoc has analyzed over 110 million patient cases and is used in nearly 2,000 hospitals worldwide, supporting care for about 60 million patients each year.
Read More:Chord Raises $7M in Funding for AI Commerce Platform








